Organization Overview
Alternative names
interferon alfa-n3 (Alferon-N) (1989 NDA)
Adenocarcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Colorectal Neoplasms (Phase 2)
Coronavirus Infections (Phase 2)
Encephalomyelitis (Phase 3)
Fatigue (Phase 3)
Fatigue Syndrome, Chronic (Phase 3)
HIV Infections (Phase 2)
HIV Seropositivity (Phase 2)
Influenza, Human (Phase 2)
Myalgia (Phase 3)
Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Syndrome (Phase 3)